James Christensen
Director/Board Member at BOUNDLESS BIO, INC.
Net worth: - $ as of 2024-03-30
Profile
Currently, James G. Christensen holds the position of Chief Scientific Officer & Executive VP at Mirati Therapeutics, Inc. He is also on the board of BCTG Acquisition Corp. In the past he was Senior Director-Oncology Precision Medicine at Pfizer Inc. Dr. Christensen received a doctorate from North Carolina State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BOUNDLESS BIO INC.
-.--% | 2024-03-27 | 0 ( -.--% ) | - $ | 2024-03-30 |
James Christensen active positions
| Companies | Position | Start |
|---|---|---|
| BOUNDLESS BIO, INC. | Director/Board Member | 2023-10-01 |
Former positions of James Christensen
| Companies | Position | End |
|---|---|---|
| MIRATI THERAPEUTICS | Chief Tech/Sci/R&D Officer | 2024-01-22 |
| PFIZER, INC. | Corporate Officer/Principal | 2012-12-31 |
| TANGO THERAPEUTICS, INC. | Director/Board Member | - |
Training of James Christensen
| North Carolina State University | Doctorate Degree |
| Northern Illinois University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| PFIZER, INC. | Health Technology |
| BOUNDLESS BIO, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Mirati Therapeutics, Inc.
 Mirati Therapeutics, Inc. BiotechnologyHealth Technology Mirati Therapeutics, Inc. operates as a clinical-stage oncology company. engages in the development of novel therapeutics. The firm's products target the genetic and immunological promoters of cancer. Its clinical pipeline consists of Adagrasib, MRTX1133, and Sitravatinib. The company was founded on December 13, 1995, and is headquartered in San Diego, CA. | Health Technology |
BCTG Acquisition Corp.
 BCTG Acquisition Corp. Financial ConglomeratesFinance BCTG Acquisition Corp. operates as a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded in May 2020 and is headquartered in San Diego, CA. | Finance |
- Stock Market
- Insiders
- James Christensen
